Category: Blog
March 23, 2022
Multicolumn Countercurrent Solvent Gradient Purification Process To Be Discussed By YMC at the World Biopharma Forum 2022
History shows that uptake of innovation is metered in the biopharma industry, but if the invention has checked all the “user need” boxes, its acceptance has an inflection point. This inflection point, when graphed, resembles a hockey stick (hopefully pointing
January 15, 2022
YMC’s BioPro is a Reliable Tool for Analyzing PEGylated Proteins
Ligand® Pharmaceuticals Inc. had an excellent success utilizing YMC’s BioProIEX to analyze PEGylated protein charge variants reproducibly. They developed a characterization method for PEGylated biotherapeutic proteins that can provide increased information without compromising peak shape and resolution and wanted to
July 12, 2021
We’re Making Moves To Serve You Better
YMC America just completed the combination and expansion of our US operations at our YMC campus in Devens, MA. This puts our columns and stationary phase team under the same roof (actually, several roofs) with the research, design, and manufacturing
January 6, 2021
YMC America Business Operations to Relocate to Devens, MA
YMC America business operations will relocate to Devens, MA, to add resources, space, and improved access to the epicenter of the global bio/pharma industry.
December 21, 2020
The YMC Prep Story
Over the years, YMC success stories for Prep LC results have been told over and over again. We are proud of our end-to-end solutions for LC method development and scale-up.
October 28, 2020
YMC-Triart Bio Phases are featured in a Q&A with LCGC magazine
As a visitor to our website, you probably already know about YMC-Triart – our family of reversed-phase stationary phases based on a chemically and mechanically stable organic/inorganic hybrid silica.
September 4, 2020
YMC-Triart Prep Bio200 C8 for Peptide Purification
There is a new YMC-Triart phase specifically designed for medium and large-scale purification of peptides. YMC-Triart Prep Bio200 C8 is an extension of the YMC-Triart product line that inherits the fundamental advantages of the YMC-Triart hybrid base particle.
November 8, 2019
See YMC At These Upcoming Events
As 2019 draws to a close, YMC will be participating in two conferences/exhibitions. If you are planning on attending either of these events, we hope you will stop by and say “Hello.”
October 28, 2019
Now Available: YMC-Triart Bio C18 Wide Pore Hybrid C18 Designed for Use with Proteins, Peptides, Oligonucleotides
Conventional C18 stationary phases are often not ideal for reversed phase separation of larger molecules such as proteins, large peptides, and oligos. This is because the pore size on the surface of the stationary phase particles is too small –
July 19, 2019
Monoclonal Antibodies (mAbs)
At YMC, we provide many choices for mAb-related separations. Some examples: Triart Bio C4 is used for reversed phase separations of intact mAbs and other large proteins. YMC BioPro HIC BF is a new phase ideal for separation of antibody
October 5, 2018
Our Newest Size Exclusion Chromatography Column for Monoclonal Antibodies: YMC-SEC MAB
At YMC America, Inc., you can buy analytical columns to meet your most demanding applications. Now, we are pleased to announce our newest analytical column: YMC-SEC MAB.
September 13, 2018
Our New Hybrid Silica ODS Product: YMC-Triart Bio C4
Chromatographers now have another tool for analyzing intact mAb’s via reversed-phase: YMC-Triart Bio C4 YMC-Triart Bio C4 was developed specifically for HPLC and UHPLC separations of intact antibodies and other large proteins. This hybrid-silica based butyl phase is especially effective
